Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Cardiac Outcomes of SGLT2i on wt-ATTR-CM

Journal article

Peer reviewed

Stefano H Byer, Aravinthasamy Sivamurugan, Udhayvir S Grewal, Michael G Fradley and Paari Dominic

The American journal of cardiology, Vol.243, pp.15-18

05/2025

DOI: 10.1016/j.amjcard.2025.01.012

PMID: 39921099

View Online

no abstract | brief report

transthyretin amyloid cardiomyopathy

SGLT2 inhibitors

tafamidis

heart failure

cardiovascular outcomes

Title: Subtitle: Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Cardiac Outcomes of SGLT2i on wt-ATTR-CM
Creators: Stefano H Byer - University of Iowa
Aravinthasamy Sivamurugan - University of Iowa, Anesthesia
Udhayvir S Grewal - University of Iowa
Michael G Fradley - University of Pennsylvania
Paari Dominic - University of Iowa
Resource Type: Journal article
Publication Details: The American journal of cardiology, Vol.243, pp.15-18
Publisher: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjcard.2025.01.012
PMID: 39921099
ISSN: 1879-1913
eISSN: 1879-1913
Language: English
Electronic publication date: 02/05/2025
Date published: 05/2025
Academic Unit: Cardiovascular Medicine; Anesthesia; Internal Medicine
Record Identifier: 9984787176502771

6 Record Views